ZyVersa Therapeutics, Inc.

The momentum for this stock is not very good. Tradey thinks it is not wise to invest in ZyVersa Therapeutics, Inc..

News

ZyVersa Therapeutics files for mixed shelf offering

SeekingAlpha.com: All News ZyVersa Therapeutics files for a $100M mixed shelf offering. Read here to know more about ZVSA stock's filing here.\n more…

ZyVersa Therapeutics files $100M mixed securities shelf

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

ZyVersa Therapeutics files to sell 478,600 shares of common stock for holders

ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) Short Interest Down 27.2% in August

Ticker Report ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA - Get Free Report) was the target of a significant decrease in short interest in August. As of August 15th, there was short interest totalling 40,900 shares, a...\n more…

ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) Sees Large Growth in Short Interest

Ticker Report ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA - Get Free Report) saw a significant growth in short interest during the month of July. As of July 31st, there was short interest totalling 56,200 shares, a...\n more…

ZVSA Stock Earnings: ZyVersa Therapeutics Beats EPS for Q2 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nZVSA stock results show that ZyVersa Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.\nThe post...\n more…